
PCSK9 and ANGPTL3 Inhibitors in Homozygous Familial Hypercholesterolemia: A Meta‑analysis of Randomized Clinical Trials
Another important International Lipid Expert Panel (ILEP) #metaanalysis on #therapy for homozygous familial #hypercholesterolemia (#HoFH) has just been published in #Drugs (IF = 14.4) by





